"There is nothing like it in the world. It is the first assay that gives you the results in minutes and it is also the first blood test for Chlamydia."

Do we need to know more?

Big, big news ahead! Unbelievable performance.

News on monday? Then directly flying to 1$.

1$ coming. This will ensure NASDAQ listing.

I think an offering would be in the range of 300 - 500 mio $.
This would imply a share price between 20 - 30$, roughly estimated.
The next weeks will be very exciting!

yeah, come on baby.

Let's see what happens today. I have put some money in this. Hopefully, I will see some of it again.
News would be great. But I do not think so. I would love to work only a few days with the co. Unfortunately, office is closed....lol

Will there any news released today?
I do not know. I am actually only asking.
Maybe the guy who was working for ten years with the co. has any idea.

1$ 1$ 1$ 1$ 1$ 1$ 1$ 1$ 1$ 1$ 1$ 1$

How do you come to this price target? Look at company's cash, look at new china deal, with double-digit royalties, no sales and distribution costs, look at big market opportunity in US or Europe.
At least (!) we should see 2 - 3$.
Maybe we have a tenbagger here.

Yes, but that's the nature of biotech stocks....
No big money without blood, sweat and tears

This is not shorting activity. It's warrants. The china deal is excellent.
Patience guys. Simply wait when no warrants are left.

I expect a b/o offer soon. I would not wait until FDA decision about P3.
The big pharma co. make their deals before.

That's the risk you have to take here. But be aware, the china deal is big. No costs associated with PTN. It is a very nice deal. When market does not react as you expect, then it is due to the warrants. Once they are away, PTN will fly.

It's simply the warrants. Nobody knows how many warrants are still left.

A lot of block trading in pre. When the opening bell rings, it's time to fly!

Pre-market is going crazy: http://www.nasdaq.com/de/symbol/ptn/premarket

This stock goes to the moon...

"Palatin has the potential to receive up to $92.5 million in sales related milestones and high single-digit to low double-digit royalties on net sales in the licensed territory."

http://www.palatin.com/investors/press-releases/

https://wallstreetwhispers.blogspot.de/2017/09/roche-viewing-european-success-of.html

Our source believes Roche board of directors plan to meet Wednesday in Basel with Delcath Systems top of the agenda.

Roche viewing European success of Melphalan/HDS to up buyout valuation for Delcath Systems (DCTH).

Roche and Delcath Systems!!!!!!!!!

Read and understand: The note holder will receive warrants with an exercise price of $0.35! Hence, the share price must be significantly higher than $0.35 so that the note holder can earn money upon conversion.

Somebody is soaking everything he can get in premarket. This could be a fantastic day.

http://delcath.com/reuters-news/?id=2296793

I still think that there is massive going on behind the scene. A very hot september is approaching.

The premarket seems to like the news.

If NO for a reverse stock split: We will see a buyout offer at 0.6-1$, imo.
Anyway, the long position is the right one

If YES for a reverse stock split: We will see 0.35$ at the lowest end, imo.

$0.35 ist 2.9 times the actual share price.

the Company and the Note Holder shall exchange $2.4M of the remaining Convertible Notes for new warrants to purchase 40M shares of Common Stock at an exercise price of $0.35.

Read more at:
https://thefly.com/landingPageNews.php?id=2601543

Delcath Systems to extinguish convertible notes with majority holder

Read more at:
https://thefly.com/landingPageNews.php?id=2601543

They will never get their 70% Yes votes for a R/S, no chance, imo. Look what is happening in Germany, a lot of rumors over there. German traders are getting loaded. They want to push this to 1$.
The CEO needs alternatives to a R/S. Delcath ready for a buyout.

https://translate.google.com/translate?sl=de&tl=en&js=y&prev=_t&hl=de&ie=UTF-8&u=http%3A%2F%2Fm.bild.de%2Fregional%2Fhannover%2Fforschung%2Fprofessor-wacker-rettet-krebs-patienten-mit-gift-52907026.bildMobile.html&edit-text=&act=url

"SPECTACULAR NEW THERAPY OF MHH RESEARCHERS" in the German News! It is Chemosat from Delcath!
Big article in the biggest newspaper in europe!
What is going on here?

https://translate.google.com/translate?sl=de&tl=en&js=y&prev=_t&hl=de&ie=UTF-8&u=http%3A%2F%2Fm.bild.de%2Fregional%2Fhannover%2Fforschung%2Fprofessor-wacker-rettet-krebs-patienten-mit-gift-52907026.bildMobile.html&edit-text=&act=url

From the article "Patient Sabine Fleischer (76) from Anderten, there were metastases, which had formed in the liver: "I did not need surgery , the body has coped well with the treatment. I am now very well, cancer cells are not visible in the MRT."

Big news ahead? Buyout coming?
There will be no R/S, but 1$ is coming, imo!

Bild is the largest newspaper in Europe!! It is read by millions in Europe. What a great promotion for Chemosat and hence Delcath.
1$ ahead!!!!!

Germany goes crazy!!!! Look at this article:

https://translate.google.com/translate?sl=de&tl=en&js=y&prev=_t&hl=de&ie=UTF-8&u=http%3A%2F%2Fm.bild.de%2Fregional%2Fhannover%2Fforschung%2Fprofessor-wacker-rettet-krebs-patienten-mit-gift-52907026.bildMobile.html&edit-text=&act=url

I think Jennifer Simpson has realized now that she will not get the votes for a R/S. Now its time for other companies to reach out for Delcath. Chemosat has been proven as a very reliable and effective system to treat liver cancer. It can be expected to be transferred to other indications. Going bankruptcy because of delisting? Now way, the company has its assets, and Chemosat alone is worth a buyout of 1$ pps, imo.
This massive increase in trading volume we have seen over the last days/weeks. I have my assumptions.....

The patent was the start for the run. Look what have been told in Hannover today. The Chemosat is the big thing in liver cancer. Share price will go up to 1$. The R/S is off the tabel. Shorts have bought their ticket to hell.